Investor · CHICAGO, IL

Eric M. Siegal

Open Eric in the network graph →

Filings

49

SEC Form D

Connections

189

co-filers

Capital

$127.4M

across filings

Active

Apr 2009

to Nov 2016

Most-connected co-filers (189)

Daniel M. Rosenbloom · CHICAGO, IL29 shared Norman S. Geller · CHICAGO, IL26 shared Barry A. Malkin · CHICAGO, IL26 shared Craig R. Caffarelli · CHICAGO, IL24 shared Michael A. Elrad · Chicago, IL20 shared Denise A. Olsen · CHICAGO, IL18 shared Arnold C. Scneider Iii · Wayne, PA14 shared N. Verdis Investment Management, Llc · West Conshohocken, PA13 shared Peter B. Finn · Boston, MA12 shared Justin Klee · Cambridge, MA9 shared Joshua Cohen · Cambridge, MA9 shared Elisabet De Los Pinos, Ph.D · Cambridge, MA9 shared Stephen D. Chubb · Cambridge, MA9 shared George Milne · Cambridge, MA7 shared Arthur M. Pappas · Durham, NC7 shared Dennis S. Guest · Columbus, OH7 shared Thomas T. Loos · Columbus, OH7 shared Christopher F. Linneman · Boston, MA7 shared Joel E. Jean-Mairet, Ph.D · Cambridge, MA7 shared Jonathan J. Desimone · Boston, MA7 shared David C. Barker · Louisville, CO7 shared Daniel M. Slane · COLUMBUS, OH7 shared Harold D. Keller · Columbus, OH7 shared Gary M. Freeman · CHICAGO, IL7 shared

Recent filings (49)

Aura Biosciences, Inc.Apr 2021 · 15 co-filers$80.5M Aura Biosciences, Inc.Jul 2020 · 24 co-filers$17.0M Amylyx Pharmaceuticals, Inc.Jul 2020 · 23 co-filers$30.0M Amylyx Pharmaceuticals, Inc.Jan 2020 · 23 co-filers$20.0M Amylyx Pharmaceuticals, Inc.Dec 2019 · 23 co-filers$15.0M Amylyx Pharmaceuticals, Inc.Dec 2019 · 23 co-filers$15.0M Aura Biosciences, Inc.Apr 2019 · 28 co-filers$40.0M Aura Biosciences, Inc.Dec 2018 · 25 co-filers$42.5M Amylyx Pharmaceuticals, Inc.Nov 2018 · 23 co-filers$13.0M Aura Biosciences, Inc.Jan 2018 · 25 co-filers$42.3M Aura Biosciences, Inc.Nov 2017 · 28 co-filers$11.5M Amylyx Pharmaceuticals, Inc.Aug 2017 · 15 co-filers$2.3M GEM REALTY EVERGREEN FUND, L.P.Nov 2016 · 17 co-filers Aura Biosciences, Inc.Sep 2016 · 30 co-filers$8.0M Amylyx Pharmaceuticals, Inc.Aug 2016 · 14 co-filers$5.0M Amylyx Pharmaceuticals, Inc.Aug 2016 · 14 co-filers$5.0M GEM REALTY FUND VI, L.P.Apr 2016 · 19 co-filers$1.0B GEM REALTY FUND VI-A, L.P.Apr 2016 · 19 co-filers$1.0B GEM REALTY EVERGREEN FUND, L.P.Nov 2015 · 19 co-filers Amylyx Pharmaceuticals, Inc.Nov 2015 · 14 co-filers$1.6M Amylyx Pharmaceuticals, Inc.Nov 2015 · 14 co-filers$1.6M Vigeo Therapeutics, Inc.Jun 2015 · 6 co-filers$10.0M SEP STRATEGIC ADVISERS FUND L.P.Apr 2015 · 15 co-filers Verdis Hedged Strategies Fund, L.P.Apr 2015 · 10 co-filers SUMERU EQUITY PARTNERS FUND L.P.Apr 2015 · 15 co-filers$600.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Eric in the interactive graph →